ORAGENICS, INC. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ORAGENICS, INC. stock issued during period, value, other for the quarter ending 2025-09-30 was $15.02M.
- ORAGENICS, INC. stock issued during period, value, other for fiscal 2023 was $8.95M.
- ORAGENICS, INC. stock issued during period, value, other for fiscal 2017 was $2.06K, a 85.72% decline from fiscal 2016.
- ORAGENICS, INC. stock issued during period, value, other for fiscal 2016 was $14.44K, a 94.53% decline from fiscal 2015.
- ORAGENICS, INC. stock issued during period, value, other for fiscal 2015 was $264.00K.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2025-09-30 | $15.02M 10-Q · filed 2025-11-07 | |
| 2023-12-31 | $8.95M 10-K · filed 2025-03-14 | |
| 2017-12-31 | $2.06K 10-K · filed 2018-02-16 | |
| 2016-12-31 | $14.44K 10-K · filed 2018-02-16 | |
| 2015-12-31 | $264.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |